Sign in
4

Changes in Ownership

BioXcel Therapeutics, Inc. Filed Acc 0001104659-23-033408

Chief Financial Officer sold 2,084 shares at $19.50 ($40,638)

  • Chief Financial Officer acquired 2,084 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Steinhart Richard I · Chief Financial Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2023-03-14 Exercise or conversion : show line 1 in the form +2,084 3,584 D
2023-03-15 Sale : show line 2 in the form −2,084 $19.50 $40,638 1,500 D
Open-market sales · 2,084 sh · avg $19.50 · $40,638

Table II: Derivative

3 lines
Date Transaction Shares Owned after D/I
2023-03-14 Exercise or conversion : show line 3 in the form Restricted Stock Units −2,084 6,253 D
2023-03-15 Grant or award : show line 4 in the form Restricted Stock Units +9,000 9,000 D
2023-03-15 Grant or award : show line 5 in the form Stock Option (Right to Buy) +32,000 32,000 D
Loading xslF345X03/tm239796-6_4seq1.xml…